Viking Therapeutics News
Top stories

Viking Therapeutics Drops 41% on Mixed Phase 2 Obesity Pill Data
Authors
42
7 months ago
Prediction markets for Viking Therapeutics
OptionProbability
50
38
28
25
21
20
14
10
10
10
6
5
Latest stories
Latest stories


